44 research outputs found

    Improved targeting of miRNA with antisense oligonucleotides

    Get PDF
    MicroRNAs (miRNAs) are a class of 20ā€“24 nt noncoding RNAs that regulate target mRNAs post-transcriptionally by binding with imperfect complementarity in the 3ā€²-untranslated region (3ā€²-UTR) and inhibiting translation or RNA stability. Current understanding of miRNA biology is limited, and antisense oligonucleotide (ASO) inhibition is a powerful technique for miRNA functionalization in vitro and in vivo, and for therapeutic targeting of miRNAs. Identification of optimal ASO chemistries for targeting miRNAs is therefore of great interest. We evaluated a number of 2ā€²-sugar and backbone ASO modifications for their ability to inhibit miR-21 activity on a luciferase reporter mRNA. ASO modifications that improved target affinity improved miRNA ASO activity, yet the positioning of high-affinity modifications also had dramatically different effects on miRNA activity, suggesting that more than affinity determined the effectiveness of the miRNA ASOs. We present data in which the activity of a modified miRNA ASO was inversely correlated to its tolerability as an siRNA passenger strand, suggesting that a similar mechanism could be involved in the dissociation of miRNA ASOs and siRNA passenger strands. These studies begin to define the factors important for designing improved miRNA ASOs, enabling more effective miRNA functionalization and therapeutic targeting

    An SREBP-Responsive microRNA Operon Contributes to a Regulatory Loop for Intracellular Lipid Homeostasis

    Get PDF
    SummarySterol regulatory element-binding proteins (SREBPs) have evolved as a focal point for linking lipid synthesis with other pathways that regulate cell growth and survival. Here, we have uncovered a polycistrionic microRNA (miRNA) locus that is activated directly by SREBP-2. Two of the encoded miRNAs, miR-182 and miR-96, negatively regulate the expression of Fbxw7 and Insig-2, respectively, and both are known to negatively affect nuclear SREBP accumulation. Direct manipulation of this miRNA pathway alters nuclear SREBP levels and endogenous lipid synthesis. Thus, we have uncovered a mechanism for the regulation of intracellular lipid metabolism mediated by the concerted action of a pair of miRNAs that are expressed from the same SREBP-2-regulated miRNA locus, and each targets a different protein of the multistep pathway that regulates SREBP function. These studies reveal an miRNA ā€œoperonā€ analogous to the classic model for genetic control in bacterial regulatory systems

    Potent inhibition of microRNA in vivo without degradation

    Get PDF
    Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately addressed in the field although it has important implications for evaluating miRNA targeting studies. Using a novel approach to quantitate miRNA levels in the presence of excess ASO, we have discovered that the outcome of miRNA inhibition can vary depending on the chemical modification of the ASO. Although some miRNA inhibitors cause a decrease in mature miRNA levels, we have identified a novel 2ā€²-fluoro/2ā€²-methoxyethyl modified ASO motif with dramatically improved in vivo potency which does not. These studies show there are multiple mechanisms of miRNA inhibition by ASOs and that evaluation of secondary endpoints is crucial for interpreting miRNA inhibition studies

    MicroRNA-122 Modulates the Rhythmic Expression Profile of the Circadian Deadenylase Nocturnin in Mouse Liver

    Get PDF
    Nocturnin is a circadian clock-regulated deadenylase thought to control mRNA expression post-transcriptionally through poly(A) tail removal. The expression of Nocturnin is robustly rhythmic in liver at both the mRNA and protein levels, and mice lacking Nocturnin are resistant to diet-induced obesity and hepatic steatosis. Here we report that Nocturnin expression is regulated by microRNA-122 (miR-122), a liver specific miRNA. We found that the 3ā€²-untranslated region (3ā€²-UTR) of Nocturnin mRNA harbors one putative recognition site for miR-122, and this site is conserved among mammals. Using a luciferase reporter construct with wild-type or mutant Nocturnin 3ā€²-UTR sequence, we demonstrated that overexpression of miR-122 can down-regulate luciferase activity levels and that this effect is dependent on the presence of the putative miR-122 recognition site. Additionally, the use of an antisense oligonucleotide to knock down miR-122 in vivo resulted in significant up-regulation of both Nocturnin mRNA and protein expression in mouse liver during the night, resulting in Nocturnin rhythms with increased amplitude. Together, these data demonstrate that the normal rhythmic profile of Nocturnin expression in liver is shaped in part by miR-122. Previous studies have implicated Nocturnin and miR-122 as important post-transcriptional regulators of both lipid metabolism and circadian clock controlled gene expression in the liver. Therefore, the demonstration that miR-122 plays a role in regulating Nocturnin expression suggests that this may be an important intersection between hepatic metabolic and circadian control

    Roles of Cabin one and Left one in T-cell development

    No full text
    Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biology, 2001.Includes bibliographical references.Cabinl binds calcineurin and myocyte enhancer factor 2 (MEF2) through the C-terminal region. In cell lines, these interactions inhibit calcineurin activity following TCR signaling and transcriptional activation of Nur77 by MEF2. The role of these interactions in vivo was investigated using a mutant mouse strain that expresses a truncated Cabin 1 lacking the C-terminal calcineurin and MEF2 binding domains. Although mutant mice exhibited normal lymphocyte development and thymocyte apoptosis, they had elevated levels of serum IgG 1, IgG2b and IgE and produced more IgG1 and IgG2b in response to a T-dependent antigen. The increased antibody production is apparently not due to changes in immunoglobulin class switching as B cells from mutant mice switched to IgG 1 at the same frequency as wildtype B cells in vitro in the presence of IL-4. However, in response to anti-CD3 stimulation, mutant T cells expressed significantly higher levels of IL-2, IL-4, IL-9, IL-13, and IFN-y. Thus, the calcineurin and MEF2 binding domain of Cabin 1 is dispensable for thymocyte development and apoptosis, but is required for proper regulation of T cell cytokine expression and Th2 antibody responses. In our analysis of gene expression in memory CD8+ T cells, we identified a member of the membrane spanning 4A gene family, MS4a4b, which we named Leftl. It was also found to be expressed in Thl, but not Th2 cells. To examine the role of Leftl in T cell development, we created transgenic mice which express Leftl in T cells. These mice revealed a role for Leftl at multiple stages of T cell development.(cont.) Ectopic expression of Leftl in CD4+CD8+ thymocytes promoted CD8+ lineage commitment, although CD4+ thymocyte development was unaffected. Although mature transgenic T cells were impaired in their response to certain stimuli in vitro, there was a dramatic increase in the proportion of memory-phenotype T cells in vivo. Finally, Th2 cytokine and GATA-3 expression was impaired in Leftl transgenic Th2 cells. Transgenic T cells activated under Th2 polarizing conditions maintained some characteristics of Thl cells, such as the expression of T-bet and IL-12 receptor. Downregulation of Leftl expression is an essential step in commitment to the Th2 lineage.by Christine C. Esau.Ph.D

    Effect of 2ā€²-sugar and phosphate backbone modifications on hybridization and anti-miR-21 activity of ASOs

    No full text
    <p><b>Copyright information:</b></p><p>Taken from "Improved targeting of miRNA with antisense oligonucleotides"</p><p>Nucleic Acids Research 2006;34(8):2294-2304.</p><p>Published online 11 May 2006</p><p>PMCID:PMC1459537.</p><p>Ā© The Author 2006. Published by Oxford University Press. All rights reserved</p> Hela cells were treated in triplicate with anti-miR-21 ASOs containing a number of 2ā€²-sugar and backbone modifications. At 24 h post transfection, cells were lysed and anti-miR-21 activity measured using the luciferase reporter assay. () 2ā€²MOE, 2ā€²-O-methoxyethyl; 2ā€²-OMe, 2ā€²-O-methyl; 2ā€²-F, 2ā€²-flouro deoxy; LNA, locked nucleic acid; PO, phosphate backbone; PS, phosphorothioate backbone. () miRCURY miRNA knockdown probe (LNA-Exiqon) compared to the 2ā€²-O-MOE-PS ASO. () Proliferation of Hela cells 24 h after transfection with various modified ASOs measured with the colorimetric CellTiter 96Ā® AQ One Solution Cell Proliferation Assay, in which absorbance at 490 nm is an indication of cell viability

    Northern blotting for miR-21 in Hela cells after transfection of 2ā€²-O-MOE-PS miR-21 ASO

    No full text
    <p><b>Copyright information:</b></p><p>Taken from "Improved targeting of miRNA with antisense oligonucleotides"</p><p>Nucleic Acids Research 2006;34(8):2294-2304.</p><p>Published online 11 May 2006</p><p>PMCID:PMC1459537.</p><p>Ā© The Author 2006. Published by Oxford University Press. All rights reserved</p> miR-21 ASO or a control ASO were transfected into Hela cells and levels of miR-21 were measured 24 h later. A control experiment in which miR-21 ASO was spiked into Hela cell lysates showed that the ASO did not interfere with miR-21 detection (spike). Cells mock transfected with low-serum media only (Optimem) or with media containing the transfection reagent (Lipofectin) also showed no reduction in miR-21 levels
    corecore